Ebola: What You Need To Know

Ebola virus disease is a serious, often fatal condition in humans and nonhuman primates. Ebola is one of several viral hemorrhagic fevers, caused by infection with a virus of the Filoviridae family, genus Ebolavirus.

The fatality rates of Ebola vary depending on the strain. For example, Ebola-Zaire can have a fatality rate of up to 90 percent while Ebola-Reston has never caused a fatality in humans.

The infection is transmitted by direct contact with the blood, body fluids, and tissues of infected animals or people. Severely ill patients require intensive supportive care. Ebola virus disease (EVD) is often characterized by the abrupt onset of fever, intense weakness, muscle pain, headache, and sore throat.

Ebola tends to spread quickly through families and friends as they are exposed to infectious secretions when caring for an ill individual. The time interval from infection with Ebola to the onset of symptoms ranges from 2-21 days.

Symptoms of Ebola

The time interval from infection with Ebola to the onset of symptoms is 2-21 days, although 8-10 days is most common.

Signs and symptoms include:

  • fever
    a headache
    joint and muscle aches
    weakness
    diarrhea
    vomiting
    stomach pain
    lack of appetite

Some patients may experience:

  • rash
    red eyes
    hiccups
    a cough
    a sore throat
    chest pain
    difficulty breathing
    difficulty swallowing
    bleeding inside and outside of the body

Laboratory tests may show low white blood cell and platelet counts and elevated liver enzymes. As long as the patient’s blood and secretions contain the virus, they are infectious. In fact, Ebola virus was isolated from the semen of an infected man 61 days after the onset of illness.

What are the treatments for Ebola?

There is currently no licensed vaccine available for Ebola. Several vaccines are being tested, but at this time, none are available for clinical use.

At the moment, treatment for Ebola is limited to intensive supportive care and includes:

  • balancing the patient’s fluids and electrolytes
    maintaining their oxygen status and blood pressure
    treating a patient for any complicating infections

Ebola vaccines

In October 2014, the World Health Organization (WHO) organized an expert consultation to assess, test, and eventually license two promising Ebola vaccines:

  • cAd3-ZEBOV – GlaxoSmithKline has developed this vaccine in collaboration with the United States National Institute of Allergy and Infectious Diseases (NIH). It uses a chimpanzee-derived adenovirus vector with an Ebola virus gene inserted.
  • rVSV-ZEBOV – this was developed by the Public Health Agency of Canada in Winnipeg with NewLink Genetics, a company, located in Ames, IA. The vaccine uses a weakened virus found in livestock; one of its genes has been replaced by an Ebola virus gene.

On July 31, 2015, Lancet published preliminary results of a vaccine trial funded and organized by the WHO; the Ebola ca Suffit vaccine had 100 percent efficacy in the trial, which took place in Guinea and involved 4,000 people. The full results of this trial were published in Lancet in February 2017.

The next step is to make these vaccines available as soon as possible – and in sufficient quantities – to protect critical frontline workers and to make a difference in the epidemic’s future evolution.

Ebola prevention

It is still unknown how individuals are infected with Ebola, so stopping infection is still difficult. Preventing transmission is achieved by:

  • ensuring all healthcare workers wear protective clothing
  • implementing infection-control measures, such as complete equipment sterilization and routine use of disinfectant
  • isolation of Ebola patients from contact with unprotected persons

Thorough sterilization and proper disposal of needles in hospitals are essential in preventing further infection and halting the spread of an outbreak.

Ebola tends to spread quickly through families and among friends as they are exposed to infectious secretions when caring for an ill individual. The virus can also spread quickly within healthcare settings for the same reason, highlighting the importance of wearing appropriate protective equipment, such as masks, gowns, and gloves.

Together with the WHO, the Centers for Disease Control and Prevention (CDC) has developed a set of guidelines to help prevent and control the spread of Ebola – Infection Control for Viral Hemorrhagic Fevers In the African Healthcare Setting.

What causes Ebola?

Ebola is caused by viruses in the Ebolavirus and Filoviridae family. Ebola is considered a zoonosis, meaning that the virus is present in animals and is transmitted to humans.

How this transmission occurs at the onset of an outbreak in humans is unknown.

In Africa, people have developed Ebola after handling infected animals found ill or dead, including chimpanzees, gorillas, fruit bats, monkeys, forest antelope, and porcupines.

Person-to-person transmission occurs after someone infected with Ebola virus becomes symptomatic. As it can take between 2 and 21 days for symptoms to develop, a person with Ebola may have been in contact with hundreds of people, which is why an outbreak can be hard to control and may spread rapidly.

How does Ebola transmission occur in humans?

Transmission of Ebola between humans can occur through:

  • Direct contact with broken skin and mucous membranes with the blood, secretions, organs, or other body fluids of infected people.
    Indirect contact with environments contaminated with such fluids.
    Exposure to contaminated objects, such as needles.
    Burial ceremonies in which mourners have direct contact with the body of the deceased.
    Exposure to the semen of people with Ebola or who have recovered from the disease – the virus can still be transmitted through semen for up to 7 weeks after recovery from illness.
    Contact with patients with suspected or confirmed EVD – healthcare workers have frequently been infected while treating patients.

There is no evidence that Ebola can be spread via insect bites.

Share this:

Source: www.medicalnewstoday.com

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.